Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits hyperglycemia-induced apoptosis in myocytes by suppressing receptor for advanced glycation end products expression
Authors:
Open Access
- 31 July 2014
- journal article
- research article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 8 (4) , 1185-1190
Abstract
Activation of the receptor for advanced glycation end products (RAGE) axis may have an important role in apoptosis. Glucagon-like peptide-1 (GLP-1) is a gut hormone that has been proposed as a therapeutic target for the treatment of diabetes, and GLP-1 receptor agonists have been reported to protect against myocardial injury associated with diabetes. The aim of the present study was to investigate the cardioprotective mechanism of exendin-4 (EX-4), a GLP-1 receptor agonist, against myocardial cell apoptosis induced by hyperglycemia. Neonatal rat ventricular myocytes were prepared by enzymatic dissociation and then cultured with high levels of glucose (HG) in the presence or absence of EX-4. Cell apoptosis was detected using an annexin V-fluorescein isothiocyanate/propidium iodide kit, and cell viability was measured using an MTT assay. RAGE expression levels and the activity of caspase-3 were assessed by western blot analysis. The results demonstrated that the incubation of myocytes with HG led to a time-dependent activation of RAGE, and the protein expression of RAGE was increased at 6 h and peaked at 24 h (P<0.05). Hyperglycemia was also found to significantly decrease cell viability and increase apoptosis (P<0.05). In addition, EX-4 significantly inhibited hyperglycemia-induced RAGE expression and the apoptosis of myocytes, and improved cell viability in a dose-dependent manner (P<0.05). When the concentration of EX-4 was 10 nM, the myocardial cell viability was significantly improved, and the levels of RAGE expression and apoptosis were significantly decreased compared with those in the HG group in the absence of EX-4 (P<0.05). Therefore, the results from the present study suggest that the cardioprotective effect induced by EX-4, a GLP-1 receptor agonist, against diabetic cardiomyopathy may be associated with the inhibition of RAGE expression.Keywords
This publication has 29 references indexed in Scilit:
- S100A14 Stimulates Cell Proliferation and Induces Cell Apoptosis at Different Concentrations via Receptor for Advanced Glycation End Products (RAGE)PLOS ONE, 2011
- Increased propensity for cell death in diabetic human heart is mediated by mitochondrial-dependent pathwaysAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Inhibition of the receptor for advanced glycation endproducts (RAGE) protects pancreatic β-cellsBiochemical and Biophysical Research Communications, 2011
- Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expressionBiochemical and Biophysical Research Communications, 2010
- Hyperglycemia-Induced Reactive Oxygen Species Increase Expression of the Receptor for Advanced Glycation End Products (RAGE) and RAGE LigandsDiabetes, 2009
- Receptor for AGE (RAGE) and its ligands—cast into leading roles in diabetes and the inflammatory responseJournal of Molecular Medicine, 2009
- Glucose induces apoptosis of cardiomyocytes via microRNA-1 and IGF-1Biochemical and Biophysical Research Communications, 2008
- RAGE and Modulation of Ischemic Injury in the Diabetic MyocardiumDiabetes, 2008
- Apoptosis in Patients with Dilated Cardiomyopathy and Diabetes: A Feature of Diabetic Cardiomyopathy?Hormone and Metabolic Research, 2007
- Involvement of Endoplasmic Reticulum Stress in Myocardial Apoptosis of Streptozocin-Induced Diabetic RatsJournal of Clinical Biochemistry and Nutrition, 2007